Great comparison thanks @bovrilburger
Does this 4C fill me with confidence that AnteoTech can submit accurate and thorough approvals i.e. TGA or FDA. Absolutely not.
- Spelling your own product incorrectly in the first sentence of your Quarterly is a bit of a boo boo.
- Having a crack at the Government (potentially your largest future buyer) is not smart for business and shows immaturity.
- Incorrect Net Cash (8.1) is concerning and
- Estimated quarters of funding available was wrong by x4 (8.5).
Come on Derek and Jack. Is is absolutely amateur. No question.
Ann: Quarterly Update and Appendix 4C, page-186
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.22M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1838 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 2160397 | 2 |
View Market Depth
| Last trade - 16.12pm 11/11/2024 (20 minute delay) ? |
| ADO (ASX) Chart |
Day chart unavailable